Holiday Sale Holiday Sale: Use code E1912JOY to save 15% on all antibodies. Ends 12/31/19. » Learn More
Epigentek Home
 
EpiGentek Guarantee

ADA Polyclonal Antibody

new product
Share:

Write a Review
Application: IF, WB
Areas of Research: Nucleotide Metabolism Antibodies
Clonality: Polyclonal
Conjugate: Unconjugated
Host: Rabbit
Isotype: IgG
Purification: Affinity Purified
Reactivity: Human, Mouse, Rat
100% Guarantee: 6 months
Catalog No.SizePriceQty
A70439-05050 µl $256.00 
A70439-100100 µl $359.00 
Why EpiGentek AntibodiesFree Shipping on Antibodies
Order now & get it by Wednesday, December 18th  
Product Overview

Background
This gene encodes an enzyme that catalyzes the hydrolysis of adenosine to inosine. Various mutations have been described for this gene and have been linked to human diseases. Deficiency in this enzyme causes a form of severe combined immunodeficiency disease (SCID), in which there is dysfunction of both B and T lymphocytes with impaired cellular immunity and decreased production of immunoglobulins, whereas elevated levels of this enzyme have been associated with congenital hemolytic anemia.

Description
ADA Polyclonal Antibody. Unconjugated. Raised in: Rabbit.

Formulation
Buffer: PBS with 0.02% sodium azide, 50% glycerol, pH7.3.

Specificity
Human, Mouse, Rat

Isotype
IgG

Uniprot ID
P00813

Purification
Affinity Purification

Immunogen
Recombinant fusion protein containing a sequence corresponding to amino acids 1-363 of human ADA (NP_000013.2).

Storage
Shipped at 4°C. Upon receipt, store at -20°C. Avoid freeze / thaw cycles

Alternative Names
ADA; adenosine deaminase

Application
WB, IF; Recommended dilution: WB 1:500 - 1:2000, IF 1:50 - 1:200

User Guide & MSDS

[User Guide]*
*Always use the actual User Guide that shipped with your product. Is the above file locked? You can also request user guides by emailing info@epigentek.com along with your contact information and institution name.

20% Off m6A Antibodies
Terms & Conditions | Privacy Policy | Site Map
Copyright © 2019 EpiGentek Group Inc. All rights reserved.